Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 10 (6) , 496-502
- https://doi.org/10.1016/j.cardfail.2004.03.006
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- β-Blocker Therapy in Heart FailureJAMA, 2002
- The role of third-generation beta-blocking agents in chronic heart failureClinical Cardiology, 1998
- Mechanism of Action of Beta-Blocking Agents in Heart FailureThe American Journal of Cardiology, 1997
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.Circulation, 1986
- Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failureThe American Journal of Cardiology, 1984
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failureThe American Journal of Medicine, 1963